U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07105956) titled 'Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.' on July 30.
Brief Summary: Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium [68Ga]-DOTA-HK-011 in neuroinflammation imaging of Alzheimer's disease.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Alzheimer's Disease (AD)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nanjing First Hospital, Nanjing Medical University
Information provided by (Responsible Party): Feng Wang, Nanjing First Hospital, Nanjing Medical University
Published by HT Digital Content Services with permission from H...